Overexpression of Pim-1 driven by the Eμ enhancer was shown to lead to a low incidence of T cell lymphomas and increased sensitivity to chemically induced T cell transformation. The gene discussed is PIM1; the disease is T-cell non-Hodgkin lymphoma.